ATE437241T1 - Verfahren zum ermitteln der wirksamkeit eines anthracyclin-antikrebsmittels - Google Patents

Verfahren zum ermitteln der wirksamkeit eines anthracyclin-antikrebsmittels

Info

Publication number
ATE437241T1
ATE437241T1 AT07120168T AT07120168T ATE437241T1 AT E437241 T1 ATE437241 T1 AT E437241T1 AT 07120168 T AT07120168 T AT 07120168T AT 07120168 T AT07120168 T AT 07120168T AT E437241 T1 ATE437241 T1 AT E437241T1
Authority
AT
Austria
Prior art keywords
anticancer agent
determining
anthracycline anticancer
susceptibility
effectiveness
Prior art date
Application number
AT07120168T
Other languages
English (en)
Inventor
Amane Harada
Tomokazu Yoshida
Original Assignee
Sysmex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sysmex Corp filed Critical Sysmex Corp
Application granted granted Critical
Publication of ATE437241T1 publication Critical patent/ATE437241T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205Phosphotransferases in general
    • G01N2333/9121Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/44Multiple drug resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT07120168T 2006-11-13 2007-11-07 Verfahren zum ermitteln der wirksamkeit eines anthracyclin-antikrebsmittels ATE437241T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006307276A JP4795203B2 (ja) 2006-11-13 2006-11-13 アンスラサイクリン系抗癌剤の感受性判定方法及びそのシステム

Publications (1)

Publication Number Publication Date
ATE437241T1 true ATE437241T1 (de) 2009-08-15

Family

ID=38969820

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07120168T ATE437241T1 (de) 2006-11-13 2007-11-07 Verfahren zum ermitteln der wirksamkeit eines anthracyclin-antikrebsmittels

Country Status (5)

Country Link
US (1) US7718393B2 (de)
EP (1) EP1921170B1 (de)
JP (1) JP4795203B2 (de)
AT (1) ATE437241T1 (de)
DE (1) DE602007001656D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12366585B2 (en) 2006-05-18 2025-07-22 Caris Mpi, Inc. Molecular profiling of tumors
EP3301446B1 (de) 2009-02-11 2020-04-15 Caris MPI, Inc. Molekulare profilierung von tumoren
JP2012527631A (ja) * 2009-05-22 2012-11-08 ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプリゼンティド・バイ・ザ・セクレタリー・デパートメント・オブ・ヘルス・アンド・ヒューマン・サービシズ タキサン型化学療法剤用のインジケータとしてのser473でのaktリン酸化反応
JP5830249B2 (ja) * 2010-03-31 2015-12-09 シスメックス株式会社 癌細胞のアンスラサイクリン系抗癌剤への感受性の判定方法及びコンピュータプログラム

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001253529B2 (en) * 2000-04-14 2006-04-27 Board Of Trustees Of The University Of Illinois Method for quantification of akt protein expression
ES2245619T1 (es) * 2002-11-05 2006-01-16 The Regents Of The University Of California Procedimientos y materiales para examinar vias asociadas a la progresion de glioblastoma.
ES2246191T1 (es) * 2002-12-11 2006-02-16 Ventana Medical Systems, Inc. Metodo para predecir la respuesta a la terapia dirigida a her2.
US20060294604A1 (en) * 2003-02-17 2006-12-28 Fridman Jordan S Model for studying the role of genes in tumor resistance to chemotherapy
JP2004357552A (ja) * 2003-06-03 2004-12-24 Hitachi Ltd 作用物質による効果推定方法及びスクリーニング方法
PT1733056E (pt) * 2004-03-31 2013-08-29 Gen Hospital Corp Método para determinar a responsividade do cancro a tratamentos visando o receptor do factor de crescimento epidérmico
WO2006082866A1 (ja) * 2005-02-01 2006-08-10 Banyu Pharmaceutical Co., Ltd. p53の機能異常の検出方法、癌の分子診断方法及び癌治療に有効な化合物の評価方法
AR053272A1 (es) * 2005-05-11 2007-04-25 Hoffmann La Roche Determinacion de responsivos a la quimioterapia

Also Published As

Publication number Publication date
EP1921170A3 (de) 2008-06-04
EP1921170B1 (de) 2009-07-22
JP2008122258A (ja) 2008-05-29
DE602007001656D1 (de) 2009-09-03
US7718393B2 (en) 2010-05-18
EP1921170A2 (de) 2008-05-14
US20080124750A1 (en) 2008-05-29
JP4795203B2 (ja) 2011-10-19

Similar Documents

Publication Publication Date Title
EP1849001A4 (de) Seitenstrom-testsatz und verfahren zum nachweis eines analyten
BRPI0915240A2 (pt) método para tratar câncer, método para avaliação de um paciente submetido ao tratamento de câncer, método para avaliação de um paciente que tem ou com suspeita de ter câncer e uso de um anticorpo anti-c-met
DE112009001602A5 (de) Vorrichtung und Verfahren zum Erfassen und Anzeigen des Rückwärtigen und/oder seitlichen Umfeldes eines Kraftfahrzeugs
EP2203209A4 (de) Kathetergerät und verfahren zur behandlung von gefässen
DE602006021611D1 (de) System zum nachweis der position eines medizinprodukts, führungssystem für ein medizinprodukt und verfahren zum nachweis der position eines medizinprodukts
EP2187829A4 (de) System und verfahren zur messung einer impedanz mittels eines katheters, z.b. eines ablationskatheters
WO2006107848A3 (en) Apparatus and methods for detecting position and migration of neurostimulation leads
EP2209495A4 (de) Taz/wwtr1 zur diagnose und behandlung von krebs
WO2010091049A3 (en) Diagnosis and treatment of cancer
WO2008095492A3 (en) A method for diagnosing atherosclerotic plaques by measurement of cd36
MX2009002951A (es) Sistema y metodo para localizar fugas de fluido en un paño de un sistema de suministro de presion reducida.
WO2013063155A3 (en) Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
DE112007003573A5 (de) Verfahren zum Bestimmen eines eine Erdimpedanz angebenden Einstellwertes und Messeinrichtung
CY1115439T1 (el) Μεθοδοι και νουκλεϊκα οξεα για αναλυσεις διαταραχων του κυτταρικου πολλαπλασιασμου
WO2008027913A3 (en) Functional assessment and treatment catheters and methods for their use in the lung
DE602006007814D1 (de) Vorrichtung und Verfahren zum Messen der Durchgangszeit des Sauerstoffes im Blut
EP2116837A4 (de) Instrument zur messung der konzentration von partikeln in einer flüssigkeit sowie messverfahren und messprogramm
DE112007000332A5 (de) Vorrichtung und Verfahren zum Bestimmen eines Freiraums vor einem Fahrzeug
EP4183338A4 (de) Vorrichtung zum nachweis von analyten in körperflüssigkeiten
ATE437241T1 (de) Verfahren zum ermitteln der wirksamkeit eines anthracyclin-antikrebsmittels
EP2164990A4 (de) Zusammensetzungen, kits und verfahren zur identifizierung, beurteilung, vorbeugung und therapie von krebs
DE502006008879D1 (de) Vorrichtung zum unterstützen eines Führens eines Fahrzeugs und Verfahren zum betreiben der Vorrichtung
WO2009022988A3 (en) Vhz for diagnosis and treatment of cancer
DE602006021038D1 (de) Verfahren zur diagnose eines ovarialkarzinoms
SG179070A1 (en) Method to identify a patient with an increased likelihood of responding to an anti-cancer agent

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties